Application Fees Going Up for Rx Drugs, Down for Biosimilars in 2018

Drug Industry Daily
A A
Application fees for prescription drug approvals will increase by nearly 20 percent in fiscal 2018, starting Oct. 1, the FDA said in a Federal Register filing.

To View This Article:

Login

Subscribe To Drug Industry Daily